Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Woods

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Health Technology Assessment (Winchester, England)|November 2, 2024
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment modelSue Harnan, Ben Kearns, Alison Scope, et al.
Discover Health Systems|July 18, 2024
Using economic analysis to inform health resource allocation: lessons from MalawiMegha Rao, Dominic Nkhoma, Sakshi Mohan, et al.
Applied Health Economics and Health Policy|June 2, 2025
Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Applied Health Economics and Health Policy|November 30, 2024
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?Abigail R Colson, Alec Morton, Christine Årdal, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Health Technology Assessment (Winchester, England)|November 2, 2024
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment modelSue Harnan, Ben Kearns, Alison Scope, et al.
Discover Health Systems|July 18, 2024
Using economic analysis to inform health resource allocation: lessons from MalawiMegha Rao, Dominic Nkhoma, Sakshi Mohan, et al.
Applied Health Economics and Health Policy|June 2, 2025
Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Applied Health Economics and Health Policy|November 30, 2024
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?Abigail R Colson, Alec Morton, Christine Årdal, et al.
Pageof 5